GlassScriptPhysician profile
Michael A Dagostino
NPI 1871595488
$1,276.20
in general payments reported to CMS, 2019-2025
17 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $69.60 · 2021: $136 · 2022: $309 · 2023: $119 · 2024: $220 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $282.18 | 2019-2025 | Precision7 |
| Tarsus Pharmaceuticals, INC. | $150.30 | 2024 | Xdemvy |
| Dompe US, INC. | $143.93 | 2022-2025 | Oxervate |
| Rxsight INC | $142.62 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Omeros Corporation | $73.82 | 2021 | |
| Abbvie INC. | $70.57 | 2023-2024 | Durysta |
| Abb Con-Cise Optical Group LLC | $66.96 | 2019 | |
| Amgen INC. | $62.92 | 2025 | Tepezza |
| Biotissue Holdings INC. | $48.81 | 2023 | |
| Novartis Pharmaceuticals Corporation | $42.02 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $41.45 | 2024 | Miebo |
| Allergan, INC. | $36.70 | 2019-2022 | |
| Horizon Therapeutics Plc | $28.24 | 2022 | |
| Sight Sciences, INC. | $24.41 | 2022 | |
| Sun Pharmaceutical Industries INC. | $23.22 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $19.83 | 2021 | |
| Harrow Eye, LLC | $18.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dagostino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.